Real World Study of Classic Infectious Disease
This study aimed to collect and analyze clinical specimens of patients with classic infectious diseases in the real world. To investigate the epidemiological distribution of classic infectious diseases (brucellosis, epidemic hemorrhagic fever, kala-azar) and treatment options suitable for China.
⁃ Brucellosis: Patients with any of the following confirmed the evidence.
• sample culture: Brucella;
• Specific antigen or antibody (IgG or IgM) positive. epidemic hemorrhagic fever:
⁃ 1 specific antibody positive 2 Hantavirus RNA positive kala-azar:
• latent infection: rK39 antibody positive
• patients with the following evidence of kala-azar diagnosis: 1) bone marrow, spleen puncture sample culture: Leishmania; 2) bone marrow, spleen puncture sample smear: Leishmania; 3) clinical symptoms, history of exposure or epidemiology, and positive screening test (rK39 positive)